Premium
FRNK blocks v‐Src‐stimulated invasion and experimental metastases without effects on cell motility or growth
Author(s) -
Hauck Christof R.,
Hsia Datsun A.,
Puente Xose S.,
Cheresh David A.,
Schlaepfer David D.
Publication year - 2002
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1093/emboj/cdf631
Subject(s) - library science , biology , computer science
Focal adhesion kinase (FAK) was first identified as a viral Src (v‐Src) substrate, but the role of FAK in Src transformation events remains undefined. We show that stable expression of the FAK C‐terminal domain (termed FRNK) in v‐Src‐transformed NIH 3T3 fibroblasts inhibited cell invasion through Matrigel and blocked experimental metastases in nude mice without effects on cell motility. FRNK inhibitory activity was dependent upon its focal contact localization. FRNK expression disrupted the formation of a v‐Src‐FAK signaling complex, inhibited p130Cas tyrosine phosphorylation, and attenuated v‐Src‐stimulated ERK and JNK kinase activation. However, FRNK did not affect v‐Src‐stimulated Akt activation, cell growth in soft agar, or subcutaneous tumor formation in nude mice. FRNK‐expressing cells exhibited decreased matrix metalloproteinase‐2 (MMP‐2) mRNA levels and MMP‐2 secretion. Transient FRNK expression in human 293 cells inhibited exogenous MMP‐2 promoter activity and overexpression of wild‐type but not catalytically‐inactive (Ala‐404) MMP‐2 rescued v‐Src‐stimulated Matrigel invasion in the presence of FRNK. Our findings show the importance of FAK in Src‐stimulated cell invasion and support a role for Src‐FAK signaling associated with elevated tumor cell metastases.